Michael Derby - 28 Sep 2022 Form 4 Insider Report for Acasti Pharma Inc. (ACST)

Role
Director
Signature
/s/ Jason Comerford, attorney-in fact for Mr. Derby
Issuer symbol
ACST
Transactions as of
28 Sep 2022
Transactions value $
$0
Form type
4
Filing time
30 Sep 2022, 16:18:16 UTC
Previous filing
01 Sep 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACST Stock Options (Right to Buy) Award $0 +85K $0.00 85K 28 Sep 2022 Class A Common Shares 85K $0.59 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Based on conversion of exercise price of C$0.80 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7321 on the date of grant.
F2 Stock options granted on 09/28/2022 under Acasti Pharma Inc.'s Stock Option Plan and become exercisable evenly and on a quarterly basis over 36 months.